Bristol-Myers Squibb: all 2,184 studies

Page 10 of 22. Open to participants first (162), then studies with results posted, then the rest; newest registration first within each.

• Observational Study of Muscle Invasive Urothelial Carcinoma Participants Treated With Adjuvant Nivolumab in FranceTerminatedNCT06421311
• Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic SyndromeTerminatedNCT06419634Phase 1
• Study to Evaluate Safety, Drug Levels, Food and Relative Bioavailability of BMS-986365 in Healthy Adult Male ParticipantsCompletedNCT06417229Phase 1
• A Study to Evaluate the Safety, Tolerability, and Drug Levels of Orally Administered BMS-986368 in Healthy Participants, Healthy Elderly Participants, and Healthy Participants of Japanese EthnicityCompletedNCT06411730Phase 1
• A Study to Assess the Effectiveness and Safety of Ozanimod in Chinese Adults With Relapsing Multiple SclerosisActive, not recruitingNCT06396039Phase 4
• COLLIGO-HCM: A Multinational Observational Study of the Real-World Effectiveness of Mavacamten Among Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)Active, not recruitingNCT06372457
• A Study to Evaluate the Effect of Cytochrome P450 (CYP) 3A Inhibitor (Itraconazole) and Inducer (Rifampin) on the Drug Levels of Golcadomide (BMS-986369) in Healthy ParticipantsCompletedNCT06363630Phase 1
• Real-World Use of Nivolumab for the Treatment of Patients With Metastatic Upper Gastrointestinal Cancer in CanadaCompletedNCT06361576
• Real-World Use of Adjuvant Nivolumab in Patients With Upper Gastrointestinal Cancer in CanadaCompletedNCT06361563
• Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell LymphomaActive, not recruitingNCT06356129Phase 3
• A Study to Assess the Drug Levels of Repotrectinib in Healthy Participants and Participants With Moderate and Severe Hepatic ImpairmentCompletedNCT06352528Phase 1
• Real-World Outcomes of Nivolumab+Ipilimumab and Pembrolizumab+Lenvatinib Among US Advanced Renal Cell Carcinoma (aRCC) PatientsCompletedNCT06345183
• Real-World Effectiveness of Mavacamten in CanadaCompletedNCT06338202
• A Study to Evaluate the Drug Levels of Mezigdomide in Adult Participants With Renal ImpairmentCompletedNCT06318676Phase 1
• A Study to Evaluate the Efficacy and Safety of Liso-cel Compared to Standard of Care in Adults With Relapsed or Refractory Follicular LymphomaWithdrawnNCT06313996Phase 3
• Real-World Practice Patterns and Outcomes of Lower-Risk Myelodysplastic Syndrome Patients in JapanCompletedNCT06298643
• Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's DiseaseActive, not recruitingNCT06268886Phase 2
• A Study to Evaluate Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic CardiomyopathyActive, not recruitingNCT06253221Phase 3
• A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Participants With Atopic DermatitisCompletedNCT06248814Phase 1
• A Study to Evaluate Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)WithdrawnNCT06232707Phase 3
• A Study to Evaluate the Absorption, Metabolism, and Excretion of Orally Administered [14C]-BMS-986368 in Healthy Male ParticipantsCompletedNCT06227975Phase 1
• A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)Active, not recruitingNCT06220201Phase 1
• A Study to Assess the Relative Bioavailability of 5 mg Mavacamten Opened Capsule Administered Via Nasogastric Tube Compared to Intact Oral 5 mg Mavacamten in Healthy ParticipantsCompletedNCT06211179Phase 1
• A Study to Compare the Efficacy and Safety of Lisocabtagene Maraleucel vs Investigator's Choice Options in Adult Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Whose Disease Has Failed Treatment With Both BTKi and BCL2i TherapiesWithdrawnNCT06205290Phase 3
• A Lactation Study in Women Receiving Treatment With OzanimodWithdrawnNCT06181630Phase 4
• A Study to Assess Health-Related Quality of Life in Patients With Hypertrophic Cardiomyopathy in JapanCompletedNCT06181617
• A Study to Assess the Effects of Itraconazole, Food, and pH on the Drug Levels of BMS-986368 in Healthy ParticipantsCompletedNCT06170723Phase 1
• A Study to Evaluate Alnuctamab in Combination With Mezigdomide in Participants With Relapsed and/or Refractory Multiple MyelomaTerminatedNCT06163898Phase 1
• A Study to Evaluate Treatment With Nivolumab Alone and Nivolumab Combined With Ipilimumab in Children With MelanomaCompletedNCT06163170
• A Study to Evaluate Satisfaction With Care in Patients With Cancer Receiving Immunotherapy Treatment at HomeCompletedNCT06163053
• A Study to Evaluate the Safety of Empliciti® (Elotuzumab) When Treating Patients With Multiple Myeloma in TaiwanCompletedNCT06163040
• Incidence of Hyperpigmentation in Black Patients With Multiple Myeloma Treated With Immunomodulatory DrugsCompletedNCT06160167
• Real-World Outcomes in Relapsed/Refractory Multiple Myeloma Patients Treated, or Eligible for Treatment, With Idecabtagene VicleucelActive, not recruitingNCT06154902
• A Study to Evaluate the Safety, Tolerability, Drug Levels, Food, Formulation, and pH Effects on Relative Absorption of BMS-986465 and Its Active Derivative BMS-986464 in Healthy ParticipantsTerminatedNCT06144697Phase 1
• A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3)Active, not recruitingNCT06140836Phase 3
• A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Multiple Sclerosis and Their InfantsActive, not recruitingNCT06133049
• A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Ulcerative Colitis and Their InfantsActive, not recruitingNCT06126835
• Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)Active, not recruitingNCT06122779Phase 2
• A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With Symptomatic Obstructive Hypertrophic CardiomyopathyActive, not recruitingNCT06112743Phase 4
• A Study to Evaluate Deucravacitinib in Participants With Moderate-to-Severe Plaque Psoriasis in GermanyActive, not recruitingNCT06104644
• A Study to Evaluate the Drug Levels, Metabolism, and Removal of BMS-986322 in Healthy Adult Male ParticipantsCompletedNCT06088264Phase 1
• A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986454 in Healthy ParticipantsCompletedNCT06086886Phase 1
• A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986446 in Healthy Participants and Healthy Participants of Japanese EthnicityCompletedNCT06084598Phase 1
• A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell TransplantationActive, not recruitingNCT06045806Phase 3
• A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome ParticipantsActive, not recruitingNCT06045689Phase 3
• A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)Active, not recruitingNCT06035497Phase 1/2
• A Study to Evaluate the Effect of Food on the Drug Levels of BMS-986196 in Healthy Adult ParticipantsWithdrawnNCT06034899Phase 1
• A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult ParticipantsCompletedNCT06027437Phase 1
• A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary FibrosisActive, not recruitingNCT06025578Phase 3
• A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of LupusCompletedNCT06013995Phase 1
• A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary FibrosisActive, not recruitingNCT06003426Phase 3
• A Study to Investigate the Effects of BMS-986278 on Drospirenone and Ethinyl Estradiol Drug Levels in Healthy Female ParticipantsCompletedNCT05985590Phase 1
• A Study to Evaluate the Drug Levels of Abatacept Converted From Drug Substance by Two Different Processes in Healthy ParticipantsCompletedNCT05981976Phase 1
• A Study to Evaluate the Drug Levels, Physical and Chemical Changes, and Removal of BMS-986196 in Healthy Male ParticipantsCompletedNCT05981963Phase 1
• A Study to Assess the Bioavailability and Effect of Food of BMS-986419 Immediate-release Tablet Formulation in Healthy Adult ParticipantsCompletedNCT05963932Phase 1
• A Study to Assess the Effect of Danicamtiv on the Drug Levels of Midazolam in Participants With Stable Heart FailureCompletedNCT05952089Phase 1
• ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood TransfusionsActive, not recruitingNCT05949684Phase 3
• A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's SyndromeActive, not recruitingNCT05946941Phase 3
• A Study to Assess the Effect of Multiple Doses of Itraconazole, Gemfibrozil, or Carbamazepine on BMS-986278 in Healthy ParticipantsCompletedNCT05932303Phase 1
• A Study to Assess the Effect of BMS-986419 on the Single Dose Drug Levels of Probe Substrates in Healthy ParticipantsCompletedNCT05932277Phase 1
• A PK Study to Assess the Drug-drug Interaction of a BCRP Inhibitor on AdagrasibCompletedNCT05924152Phase 1
• A Study to Assess the Effect of Phenytoin on the Drug Levels of Afimetoran and the Effect of Afimetoran on the Drug Levels of MidazolamCompletedNCT05901714Phase 1
• A Study to Compare the Relative Bioavailability of Two Iberdomide (CC-220) Formulations and to Assess The Effect Of Food on the Drug Levels of Iberdomide in Healthy Adult ParticipantsCompletedNCT05899738Phase 1
• A Study to Evaluate the Drug-drug Interaction of BMS-986196 With Oral Contraceptives in Healthy Female ParticipantsCompletedNCT05891262Phase 1
• A Study to Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in IndiaActive, not recruitingNCT05891249Phase 4
• A Study of BMS-986449 With and Without Nivolumab in Participants With Advanced Solid TumorsActive, not recruitingNCT05888831Phase 1/2
• A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)Active, not recruitingNCT05869955Phase 1
• A PK Study to Assess the Drug-drug Interaction of a Strong CYP2C8 Inhibitor on AdagrasibCompletedNCT05868356Phase 1
• A Study to Assess the Effect of Famotidine on the Drug Levels of Afimetoran in Healthy ParticipantsCompletedNCT05866627Phase 1
• Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)Active, not recruitingNCT05853575Phase 2
• A Study to Evaluate the Drug-drug Interaction Potential of BMS-986196 in Healthy ParticipantsCompletedNCT05852769Phase 1
• A Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]BMS-986419 in Healthy Male ParticipantsCompletedNCT05847439Phase 1
• Adagrasib in Combination With Nab-Sirolimus in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer With a KRAS G12C Mutation (KRYSTAL -19)TerminatedNCT05840510Phase 1
• DeteCtiON and Stroke PreventIon by MoDEl ScRreenING for Atrial FibrillationCompletedNCT05838781Not applicable
• A Phase 1 Study to Evaluate the Potential Drug Interactions Between Repotrectinib and Metformin, Digoxin, and Rosuvastatin in Patients With Advanced Solid TumorsWithdrawnNCT05828303Phase 1
• A Phase 1 Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics of Repotrectinib in Advanced Cancer PatientsWithdrawnNCT05828277Phase 1
• A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple MyelomaActive, not recruitingNCT05827016Phase 3
• A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986325 in Healthy Japanese ParticipantsCompletedNCT05813717Phase 1
• A Study to Describe the Persistence With Ozanimod Treatment in Relapsing-Remitting Multiple Sclerosis (RRMS) ParticipantsActive, not recruitingNCT05811416
• A Study to Evaluate the Safety, Tolerability, and Drug Levels of Danicamtiv in Healthy Japanese and Caucasian ParticipantsCompletedNCT05806359Phase 1
• A Study to Evaluate the Drug Levels, Safety, and Tolerability of BMS-986278 in Healthy Chinese ParticipantsCompletedNCT05805904Phase 1
• A Study to Evaluate Nivolumab in the Treatment of Early Stage Esophageal or Gastroesophageal CancerTerminatedNCT05780736
• A Study to Evaluate Nivolumab in Japanese Participants With Muscle-invasive Urothelial CarcinomaActive, not recruitingNCT05779592
• A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986447 in Healthy ParticipantsCompletedNCT05760937Phase 1
• A Study to Evaluate Treatment Preferences for Japanese Participants With Muscle-invasive Urothelial Carcinoma of the BladderCompletedNCT05742867
• Study of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D MutationTerminatedNCT05737706Phase 1
• A Study to Evaluate the Effects of Mavacamten in Healthy ParticipantsCompletedNCT05719805Phase 1
• A Study of Mezigdomide in Healthy Participants and Participants With Hepatic ImpairmentCompletedNCT05707390Phase 1
• A Rollover Study of CC-122Active, not recruitingNCT05688475Phase 1
• A Study to Evaluate the Absorption, Metabolism, and Excretion (ADME) of BMS-986435CompletedNCT05686096Phase 1
• A Study Investigating the Safety, Tolerability, Drug Levels and Drug Effect of BMS-986278 in Healthy Adult Participants (Part 1) and Japanese Participants (Part 2)CompletedNCT05684289Phase 1
• A Study of Absorption, Metabolism, and Elimination CC-90010 in Participants With Advanced Solid TumorsWithdrawnNCT05678283Phase 1
• A Study to Assess Real-World Patient-Reported Outcomes With Fedratinib for Myelofibrosis Post-RuxolitinibCompletedNCT05665192
• A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-ThalassemiaActive, not recruitingNCT05664737Phase 2
• A Study to Describe the Switching From a First- or Second-line Disease Modifying Therapy (DMT) to Ozanimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)CompletedNCT05658601
• A Study to Assess the Effects on the Single-Dose Drug Levels of Mavacamten in Healthy ParticipantsCompletedNCT05658146Phase 1
• A Study to Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC)TerminatedNCT05644665Phase 3
• A Study to Evaluate the Safety and Tolerability of Cendakimab in Chinese Healthy ParticipantsCompletedNCT05638282Phase 1
• A Study to Assess Deucravacitinib Post-marketing Surveillance in Participants With Psoriasis in JapanCompletedNCT05633264
• A Study of BMS-986360/CC-90001 Alone and in Combination With Chemotherapy or Nivolumab in Advanced Solid TumorsCompletedNCT05625412Phase 1

← Bristol-Myers Squibb overview and focus areas